Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.

Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.

J Clin Endocrinol Metab. 2017 Jun 01;102(6):2112

Authors: Lamy O, Gonzalez-Rodriguez E, Aubry-Rozier B

PMID: 28586456 [PubMed - in process]

http://ift.tt/2rL6E0C


http://ift.tt/2sT7GXz